Intravitreal Injection Technique

REFERENCES

• Ohm J. Über die Behandlung der Netzhautablösung durch operative Entleerung der subretinalen Flüssigkeit und Einspritzen vom Luft in den Glaskörper. Graefe Arch Klin Ophthalmol 1911;79:442–450.
   Google Scholar
• Schneider J, Frankel SS. Treatment of late postoperative intraocular infections with intraocular injection of penicillin. Arch Ophthalmol 1947;37:304–307.
   Web of Science ®Google Scholar
• FDA website: http://www.accessdata.fda.gov/Scripts/cder/DrugsatFDA/
   Google Scholar
• Fung AE, Rosenfeld PJ, Reichel E. The International Intravitreal Bevacizumab Safety Survey: Using the internet to assess drug safety worldwide. Br J Ophthalmol 2006;90(11):1344–9.
   PubMedGoogle Scholar
• Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Singerman LJ, Tolentino M, Chan CK, Gonzalez VH. Score Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 2009;127(9):1101-14.
   Google Scholar
• Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, Rundle AC, Rubio RG, Murahashi WY, CRUISE Investigators. Ranibizumab for macular edema following central retinal vein occlusion six-month primary end point results of a phase III study. Ophthalmology 2010;117(6):1124-33.
   Google Scholar
• Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR. VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age- related macular degeneration. N Engl J Med 2004;351:2805–16.
   PubMed Web of Science ®Google Scholar
• Jager RD, Aiello LP, Patel SC, Cunningham ET Jr. Risks of intravitreous injection: Acomprehensive review. Retina 2004;24(5):676-98.
   PubMedGoogle Scholar
• Schwartz SG, Flynn HW, Scott IU. Endophthalmitis after intravitreal injections. Expert Opin Pharmacother 2009;10(13):2119-26.
   Google Scholar
• Fintak DR, Shah GK, Blinder KJ, Regillo CD, Pollack J, Heier JS, Hollands H, Sharma S. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina 2008;28(10):1395-9.
   PubMedGoogle Scholar
• Fung AE, Bhisitkul RB. Safety monitoring with ocular anti-vascular endothelial growth factor therapies. Br J Ophthalmol 2008;92(12):1573-4.
   PubMedGoogle Scholar
• Aiello LP, Brucker AJ, Chang S, Cunningham ET Jr, D’Amico DJ, Flynn HW Jr, Grillone LR, Hutcherson S, Liebmann JM, O’Brien TP, Scott IU, Spaide RF, Ta C, Trese MT. Evolving guidelines for intravitreous injections. Retina 2004;24(5 Suppl):S3–19.
   Google Scholar
• Anijeet DR, Hanson RJ, Bhagey J, Bates RA. National survey of the technique of intravitreal triamcinolone injection in the United Kingdom. Eye (Lond) 2007;21(4):480-6.
   PubMedGoogle Scholar
• Charles S, Rosenfeld PJ, Gayer S. Medical consequences of stopping anticoagulant therapy before intraocular surgery or intravitreal injections. Retina 2007;27(7):813-5.
   PubMedGoogle Scholar
• Meyer CH, Callizo J, Mennel S, Kussin A. Perioperative management of anticoagulated patients undergoing repeated intravitreal injections. Arch Ophthalmol 2007;125:994.
   PubMedGoogle Scholar
• Isenberg SJ, Apt L, Yoshimori R, Khwarg S. Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic. Arch Ophthalmol 1985;103(9):1340-2.
   PubMedGoogle Scholar
• Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Newton J, Miller D. Acute-onset endophthalmitis after cataract surgery (2000–2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol 2005;139(6):983–987.
   Google Scholar
• Bylsma G, Guymer R, Qureshi S, Gin T, Allen P, Madhok P, McCombe M, Harper A. Intravitreous injections. Clin Experiment Ophthalmol 2006;34(4):388-90.
   Google Scholar
• Ziemssen F, Wiedemann P, Kampik A, Holz F, Bartz-Schmidt KU. [Intravitreal injections of medications in Germany. Contract situation and legal conditions]. Ophthalmologe 2009;106(5):465-70.
   PubMedGoogle Scholar
• Schmidt-Erfurth UM, Richard G, Augustin A, Aylward WG, Bandello F, Corcòstegui B, Cunha-Vaz J, Gaudric A, Leys A, Schlingemann RO; European Society for Retina Specialists’ Guidelines Committee (EURETINA). Guidance for the treatment of neovascular age-related macular degeneration. Acta Ophthalmol Scand 2007;85:486–494.
   PubMedGoogle Scholar
• Bakri SJ, Pulido JS, McCannel CA, Hodge DO, Diehl N, Hillemeier J. Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye (Lond) 2009;23(1):181-5.
   Google Scholar
• Cintra LP, Lucena LR, Da Silva JA, Costa RA, Scott IU, Jorge R. Comparative study of analgesic effectiveness using three different anesthetic techniques for intravitreal injection of bevacizumab. Ophthalmic Surg Lasers Imaging 2009;40(1):13-8.
   PubMedGoogle Scholar
• Intravitreal Injection Survey. Anti-infection procedures are still evolving. Retin Physician 2006. www.retinalphysician.com/article.aspx?article=&loc=archive\2006\may\0506055.htm. Accessed December 8, 2009.
   Google Scholar
• Knecht PB, Michels S, Sturm V, Bosch MM, Menke MM. Tunnelled versus straight intravitreal injection: Intraocular pressure changes, vitreous reflux, and patient discomfort. Retina 2009;29(8):1175-81.
   PubMedGoogle Scholar
• Fung AE, Lalwani GA, Rosenfeld PJ, Dubovy SR, Michels S, Feuer WJ, Puliafito CA, Davis JL, Flynn HW Jr, Esquiabro M. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007;143(4):566-83.
   PubMedGoogle Scholar
• Kozak I, Cheng L, Freeman WR. Lidocaine gel anesthesia for intravitreal drug administration. Retina 2005;25(8):994-8.
   PubMedGoogle Scholar
• Page MA, Fraunfelder FW. Safety, efficacy, and patient acceptability of lidocaine hydrochloride ophthalmic gel as a topical ocular anesthetic for use in ophthalmic procedures. Clin Ophthalmol 2009;3:601–9.
   PubMedGoogle Scholar
• Boden JH, Myers ML, Lee T, Bushley DM, Torres MF. Effect of lidocaine gel on povidone-iodine antisepsis and microbial survival. J Cataract Refract Surg 2008;34(10):1773–1775.
   PubMedGoogle Scholar
• Park HS, Kim MS. The inflammatory potential of surgical glove lubricants: Biosorb, Keoflo, calcium carbonate and Hydrocote after intravitreal injection. Korean J Ophthalmol 1997;11:51–59.
   PubMedGoogle Scholar
• Namdari H, Kintner K, Jackson BA, Namdari S, Hughes JL, Peairs RR, Savage DJ. Abiotrophia species as a cause of endophthalmitis following cataract extraction. J Clin Microbiol 1999;37(5):1564-6.
   PubMedGoogle Scholar
• Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology 1991;98:1769–75.
   PubMed Web of Science ®Google Scholar
• Lachapelle JM. Allergic contact dermatitis from povidone-iodine: A re-evaluation study. Contact Dermatitis 2005;52(1):9-10.
   PubMedGoogle Scholar
• Barkana Y, Almer Z, Segal O, Lazarovitch Z, Avni I, Zadok D. Reduction of conjunctival bacterial flora by povidone-iodine, ofloxacin and chlorhexidine in an outpatient setting. Acta Ophthalmol Scand 2005;83(3):360-3.
   PubMedGoogle Scholar
• Kiffney GT, Hattaway AC. Povidone-iodine as an ophthalmic antiseptic. Surg Forum 1966;17:434–435.
   PubMedGoogle Scholar
• Ferguson AW, Scott JA, McGarigan J et al. Comparison of 5% povidone-iodine solution against 1% povidone iodine solution in preoperative cataract surgery antisepsis: A prospective randomised double blind study. Br J Ophthalmol 2003;87:163–167.
   PubMed Web of Science ®Google Scholar
• Safar A, Dellimore MC. The effect of povidone iodine flush versus drops on conjunctival colonization before intravitreal injections. Int Ophthalmol 2007;27(5):307-12.
   PubMedGoogle Scholar
• Pulido JS, Zobitz ME, An K-N. Scleral penetration force requirements for commonly used intravitreal needles. Eye 2007;21:1210–1211.
   PubMedGoogle Scholar
• Bakri SJ, Ekdawi NS. Intravitreal silicone oil droplets after intravitreal drug injections. Retina 2008;28(7):9961–001.
   Google Scholar
• Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, Antoszyk AN. SCORE Study Investigator Group. SCORE Study Report 7: Incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design. Am J Ophthalmol 2009;148(5):725–732.e7.
   PubMedGoogle Scholar
• Peyman GA, Lad EM, Moshfeghi DM. Intravitreal injection of therapeutic agents. Retina 2009;29(7):875–912.
   Google Scholar
• Carsten HM, Fung AE, Saxena S, Frank GH. Steps for a Safe Intravitreal Injection Technique: A look at how European and American approaches compare. Retinal Physician 2009 Jul.
   Google Scholar
• Friedrich S, Cheng YL, Saville B. Drug distribution in the vitreous humor of the human eye: The effects of intravitreal injection position and volume. Curr Eye Res 1997;16:663–669.
   PubMed Web of Science ®Google Scholar
• Rodrigues EB, Meyer CH, Grumann A Jr, Shiroma H, Aguni JS, Farah ME. Tunneled scleral incision to prevent vitreal reflux after intravitreal injection. Am J Ophthalmol 2007;143(6):1035-7.
   PubMedGoogle Scholar
• Chen SD, Mohammed Q, Bowling B, Patel CK. Vitreous wick syndrome—A potential cause of endophthalmitis after intravitreal injection of triamcinolone through the pars plana. Am J Ophthalmol 2004;137(6):1159-60.
   Google Scholar
• Hubschman JP, Coffee RE, Bourges JL, Yu F, Schwartz SD. Experimental model of intravitreal injection techniques. Retina 2010;30(1):167-73.
   Google Scholar
• Bakri SJ, Risco M, Edwards AO, Pulido JS. Bilateral simultaneous intravitreal injections in the office setting. Am J Ophthalmol 2009;148(1):66-9.
   PubMedGoogle Scholar
• Hayreh SS, Zimmerman MB, Kimura A, Sanon A. Central retinal artery occlusion. Retinal survival time. Exp Eye Res 2004;78:723–36.
   PubMed Web of Science ®Google Scholar
• Kim JE, Mantravadi AV, Hur EY, Covert DJ. Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents. Am J Ophthalmol 2008;146(6):930-4.
   Google Scholar
• Hosseini H, Razeghinejad MR. Anterior ischemic optic neuropathy after intravitreal injection of bevacizumab. J Neuroophthalmol 2009;29(2):160-1.
   PubMedGoogle Scholar